Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.67 |
| ▸ | CTSC | P53634 | 2/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | ECE1 | P42892 | 1/20 | 0.49 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.49 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31174322 | 1.00 | MME (0.67) | MMECTSCALPIPKMPTGS1 | |
| SCHEMBL8525812 | 1.00 | MME (0.67) | MMECTSCALPIPKMPTGS1 | |
| SCHEMBL29543743 | 0.95 | MME (0.61) | MMECTSCALPIPKMPTGS1 | |
| SCHEMBL30735658 | 0.93 | OPRD1 (0.62) | MMECTSCALPIPKMPTGS1 | |
| SCHEMBL31215109 | 0.93 | OPRD1 (0.62) | MMECTSCALPIPKMPTGS1 | |
| SCHEMBL1711844 | 0.92 | MME (0.58) | MMECTSCALPIPKMPTGS1 | |
| SCHEMBL29377179 | 0.92 | MME (0.57) | MMECTSCALPIPKMPTGS1 | |
| SCHEMBL31215083 | 0.91 | OPRD1 (0.60) | MMECTSCOPRM1OPRD1 | |
| SCHEMBL29351955 | 0.91 | CTSD (0.57) | MMECTSCALPIPKMPTGS1 | |
| SCHEMBL30974432 | 0.90 | MME (0.56) | MMECTSCOPRM1OPRD1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250155441-A1 | HIGH AFFINITY ANTIBODIES SPECIFICALLY BINDING TO a-1,6-CORE-FUCOSYLATED ALPHA-FETOPROTEIN | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2025-05-15 | — | — | US | disclosed |
| EP-4526341-A1 | HIGH AFFINITY ANTIBODIES SPECIFICALLY BINDING TO ALPHA-1,6-CORE-FUCOSYLATED ALPHA-FETOPROTEIN | F. Hoffmann-La Roche AG (CH) | 2025-03-26 | — | — | EP | disclosed |
| CN-119213025-A | High affinity antibodies that specifically bind to alpha-1, 6-core-fucosylated alpha-fetoprotein | 豪夫迈·罗氏有限公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2023222543-A1 | High Affinity Antibodies Specifically Binding to α-1,6-Core-Fucosylated Alpha-Fetoprotein | F. HOFFMANN-LA ROCHE AG (CH) | 2023-11-23 | — | — | WO | disclosed |
| CN-114224908-A | Application of cordyceps militaris polysaccharide in preparation of product for regulating intestinal flora and metabolite disorder caused by high-fat diet | 暨南大学 | 2022-03-25 | — | — | CN | disclosed |
| EP-0885899-A1 | Method for obtaining peptide fragments by use of fluorinated organic acids | SEIKO INSTRUMENTS INC. (JP) | 1998-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250155441-A1 | HIGH AFFINITY ANTIBODIES SPECIFICALLY BINDING TO a-1,6-CORE-FUCOSYLATED ALPHA-FETOPROTEIN | FUCA1, FUCA2, FUT4 | MME 1897/4885CTSC 1995/4885ALPI 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.